Profound Medical to Release Third Quarter 2020 Financial Results on November 5 – Conference Call to Follow

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, will announce its third quarter 2020 financial results after market close on Thursday, November 5, 2020.